Published in AIDS Weekly, December 18th, 1995
Each year, approximately 200,000 to 300,000 hepatitis B virus (HBV) infections and 150,000 hepatitis C virus (HCV) infections occur in the United States. Injection drug users are among those at highest risk for both types of viral hepatitis. Studies conducted in Europe and the United States with this population have found serologic evidence of HBV infection in 65 percent to 95 percent of intravenous drug users and evidence of HCV infection in 65 percent to 80...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.